Chris Manhertz

Tight End

Age: 31
Free Agency: 2025 (UFA)
Accrued Seasons: 7
  • 2023 Salary Cap Charge: $2,725,000 (1.17% of cap)
  • 2023 Cash Payout: $3,350,000 (1.26% of spending)
  • 2023 Cash to Cap Ratio: 1.23
  • Contract Value: $6,000,000 ($3,000,000 APY)
  • Fully Guaranteed Money: $3,340,000
  • Contract Ranking: 33/183 at TE

Current Contract

(UFA, signed 2023)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202331$1,590,000$625,000$510,000$1,590,000$2,725,0001.2%
202432$2,140,000$625,000$510,000$500,000$3,275,0001.3%
Total$3,730,000$1,250,000$1,020,000$2,090,000$6,000,000

Contract Notes

Chris Manhertz signed a two year, $6 million contract with the Broncos. $3.34 million is fully guaranteed.

Cash Flows

- fully earned money
- unearned or partially earned money
$3M
$6M
20232024
Cash Due$3,350,000$2,650,000
Running Cash$3,350,000$6,000,000
Career Earnings: $12,012,200
Career APY: $1,501,525
Potential Earnings: $16,603,376
Total Guarantees: $7,910,000
Largest Cash Payment: $3,750,000 (2021)
Largest Cap Number: $4,025,000 (2022)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
PanthersSFAExpired20162$990,000$495,000$0$831,17684.0%$415,588
PanthersERFAExpired20181$630,000$630,000$0$630,000100.0%$630,000
PanthersUFAExpired20192$2,300,000$1,150,000$320,000$2,380,000103.5%$1,190,000
JaguarsUFAExpired20212$6,650,000$3,325,000$4,250,000$6,650,000100.0%$3,325,000
BroncosUFAActive20232$6,000,000$3,000,000$3,340,000$1,250,00020.8%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Saints1$271,024$271,024$112,2000.0%$158,8240.0%
Panthers5$3,841,176$768,235$3,841,1760.0%$00.0%
Jaguars2$6,650,000$3,325,000$6,650,0000.0%$00.0%
Broncos0$1,250,000$0$00.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2015Saints$112,200$0$0$0$0$112,2000.1%$112,200
2016Panthers$450,000$0$0$0$0$291,1760.2%$291,176
2017Panthers$540,000$0$0$0$0$540,0000.3%$540,000
2018Panthers$630,000$0$0$0$0$630,0000.3%$630,000
2019Panthers$720,000$160,000$160,000$50,000$0$1,090,0000.6%$1,240,000
2020Panthers$910,000$160,000$160,000$70,000$0$1,290,0000.6%$1,140,000
2021Jaguars$1,000,000$1,125,000$300,000$200,000$1,000,000$2,625,0001.3%$3,750,000
2022Jaguars$2,400,000$1,125,000$300,000$200,000$1,000,000$4,025,0001.7%$2,900,000
2023Broncos$1,590,000$625,000$510,000$0$1,590,000$2,725,0001.2%$3,350,000
2024Broncos$2,140,000$625,000$510,000$0$500,000$3,275,0001.3%$2,650,000
Total$10,492,200$3,820,000$1,940,000$520,000$4,090,000$16,603,376$16,603,376
Dead Money History
TeamYearCap ChargeCash Paid
Saints2016$158,824$158,824
Total$158,824$158,824

Statistics

YearGames PlayedGames InactiveSnapsRushingReceivingFumbles
InjuredHealthyOffenseSpecialAttYardsAvgTDRecYardsAvgTDTotalLost
20167154.8%14.2%000.0011010.0000
2017160027.0%25.9%000.002178.5000
2018160032.5%26.6%000.0025226.0100
2019151030.7%20.8%000.0011111.0000
2020160048.7%18.9%000.006528.7000
2021170036.0%13.4%000.0067111.8100
2022170038.0%36.7%000.006427.0000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$2,519,000$3,000,000
Injury Adjusted$2,519,000$3,000,000
test
OTC Valuation $2.1M $4.2M $6.4M $8.5M $10.6M APY $2.8M $5.7M $8.5M $11.3M $14.2M $6,305,000 $7,500,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.